Aerocrine supplies instruments for nitric oxide (NO) measurements, a biological marker for airway inflammation. Measuring NO levels offers strong clinical benefits when diagnosing, monitoring and predicting exacerbations for asthma patients. Aerocrine’s products are world-leading for the routine measurement of the underlying inflammation in asthma.
- Sector: Healthcare
- Status: Public (STOCKHOLM: AERO)
- Geographic Market: Europe
- Investment Year: 1999
- Board Representation: Thomas Eklund
Visit the company’s website.
